H.R. 690 (119th)Bill Overview

To prohibit the use of Federal funds to implement Salmonella framework for raw poultry products.

Agriculture and Food|Agriculture and Food
Cosponsors
Support
Republican
Introduced
Jan 23, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Subcommittee on Livestock, Dairy, and Poultry.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill bars any Federal funds from being used to finalize, implement, administer, or enforce the Food Safety and Inspection Service's proposed "Salmonella Framework for Raw Poultry Products" published August 7, 2024 (89 Fed. Reg. 64678).

Why people may split

Public health protection versus regulatory burden on producers

Watch point

Relative to its intended legislative type, this bill presents a concise and legally specific operational prohibition, clearly identifying the regulatory action to be blocked.

The bill bars any Federal funds from being used to finalize, implement, administer, or enforce the Food Safety and Inspection Service's proposed "Salmonella Framework for Raw Poultry Products" published August 7, 2024 (89 Fed.

Reg. 64678).

It specifically prohibits funding related to that proposed rule and determination.

Passage25/100

Very narrow but politically charged; easier to advance as an appropriations rider than as standalone statute, though opponents include public-health stakeholders.

CredibilityPartially aligned

Relative to its intended legislative type, this bill presents a concise and legally specific operational prohibition, clearly identifying the regulatory action to be blocked. It succeeds at naming the target and prescribing the prohibited uses of funds but provides minimal guidance on implementation, fiscal treatment, enforcement, or handling of edge cases.

Contention70/100

Public health protection versus regulatory burden on producers

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedFederal agencies · States

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitReduces immediate regulatory compliance costs for poultry processors and producers.
  • Potential benefitAvoids administrative burdens on USDA/FSIS associated with implementing the proposed framework.
  • Potential benefitMay prevent capital expenditures or plant modifications that the rule might have required.
Likely burdened
  • Federal agenciesCould hinder a coordinated federal effort to reduce Salmonella in raw poultry products.
  • Potential burdenMay increase foodborne illness risk and associated healthcare and productivity costs.
  • StatesCould produce uneven state-level standards, complicating interstate commerce and compliance.
03 · Why people split

Why the argument around this bill splits.

Public health protection versus regulatory burden on producers
Progressive10%

Likely opposes the bill as undermining a public-health regulatory effort aimed at reducing Salmonella in poultry.

Views the prohibition as favoring industry compliance costs over consumer safety and agency science.

Likely resistant
Centrist45%

Views the bill with caution; finds merit in pausing a major rule until costs and implementation impacts are clear.

Wants a balanced outcome that protects public health while avoiding undue burdens on producers.

Split reaction
Conservative80%

Likely supports the bill as a check on regulatory overreach that could impose costs on poultry producers.

Sees fund prohibition as protecting producers, rural economies, and limiting federal intrusion.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood25/100

Very narrow but politically charged; easier to advance as an appropriations rider than as standalone statute, though opponents include public-health stakeholders.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Absent cost or regulatory impact analysis in text
  • Level of industry or public-health stakeholder mobilization
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Public health protection versus regulatory burden on producers

Very narrow but politically charged; easier to advance as an appropriations rider than as standalone statute, though opponents include publ…

Unlocked analysis

Relative to its intended legislative type, this bill presents a concise and legally specific operational prohibition, clearly identifying the regulatory action to be blocked. It succeeds at naming the target and prescri…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis